Barclays PLC boosted its holdings in shares of Proto Labs, Inc. (NYSE:PRLB – Free Report) by 66.4% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 42,633 shares of the industrial products company’s stock after purchasing an additional 17,017 shares during the quarter. Barclays PLC owned about 0.17% of Proto Labs worth $1,252,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in PRLB. Marshall Wace LLP boosted its position in shares of Proto Labs by 81.6% in the second quarter. Marshall Wace LLP now owns 42,800 shares of the industrial products company’s stock valued at $1,322,000 after acquiring an additional 19,232 shares during the period. State Street Corp boosted its holdings in Proto Labs by 1.4% in the 3rd quarter. State Street Corp now owns 965,426 shares of the industrial products company’s stock valued at $28,355,000 after purchasing an additional 13,554 shares during the period. Dynamic Technology Lab Private Ltd acquired a new stake in Proto Labs in the 3rd quarter worth $753,000. Jane Street Group LLC grew its position in Proto Labs by 107.4% in the 3rd quarter. Jane Street Group LLC now owns 97,623 shares of the industrial products company’s stock worth $2,867,000 after purchasing an additional 50,556 shares during the last quarter. Finally, Quest Partners LLC increased its holdings in shares of Proto Labs by 146.5% during the 2nd quarter. Quest Partners LLC now owns 30,403 shares of the industrial products company’s stock worth $939,000 after purchasing an additional 18,068 shares during the period. Institutional investors and hedge funds own 84.54% of the company’s stock.
Wall Street Analyst Weigh In
Several equities analysts recently issued reports on PRLB shares. Craig Hallum boosted their price target on Proto Labs from $30.00 to $36.00 and gave the company a “hold” rating in a research note on Monday, November 4th. Needham & Company LLC restated a “hold” rating on shares of Proto Labs in a research note on Friday, November 1st. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $40.00 target price on shares of Proto Labs in a research report on Monday, November 4th. Two research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, Proto Labs presently has an average rating of “Moderate Buy” and a consensus target price of $40.33.
Proto Labs Trading Down 1.9 %
Shares of NYSE PRLB opened at $39.56 on Monday. Proto Labs, Inc. has a 1-year low of $25.75 and a 1-year high of $45.15. The company has a 50-day moving average of $38.09 and a two-hundred day moving average of $32.96. The company has a market cap of $969.62 million, a PE ratio of 42.09 and a beta of 1.45.
Proto Labs (NYSE:PRLB – Get Free Report) last announced its quarterly earnings data on Friday, November 1st. The industrial products company reported $0.47 EPS for the quarter, beating analysts’ consensus estimates of $0.32 by $0.15. Proto Labs had a return on equity of 3.49% and a net margin of 4.76%. The firm had revenue of $125.60 million for the quarter, compared to analyst estimates of $121.38 million. During the same period last year, the company earned $0.31 EPS. The business’s quarterly revenue was down 3.9% compared to the same quarter last year. As a group, equities research analysts forecast that Proto Labs, Inc. will post 0.84 earnings per share for the current year.
About Proto Labs
Proto Labs, Inc, together with its subsidiaries, operates as a digital manufacturer of custom parts in the United States and Europe. The company offers injection molding; computer numerical control machining; three-dimensional printing; and sheet metal fabrication products. It serves developers and engineers, who use 3D computer-aided design software to design products across a range of end-markets.
See Also
- Five stocks we like better than Proto Labs
- What Are Dividend Champions? How to Invest in the Champions
- Power Up: Gaming Industry Expansion Fuels Stock Opportunities
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- These 3 Quirky ETFs May Be Strong Plays in 2025
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
Receive News & Ratings for Proto Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proto Labs and related companies with MarketBeat.com's FREE daily email newsletter.